Recent work suggested a potential collaboration between Rac1 and the CCL2-CCR4 axis in promoting cell migration and cancer metastasis, emphasizing the potential significance of statins in reducing Rac1 prenylation and thereby function toward enhancing HNSCC treatment outcomes [102]. The gene discussed is RAC1; the disease is cancer.